Synthesis of isotopically labeled 2-pyridinyloxyisobubanoic acid, a building block for CB-1 inhibitors as drug candidates for obesity treatment

MEDI 33

Jonathan Z. Ho, jonathan_ho@merck.com and Matthew P Braun, matt_braun@merck.com. Department of Drug Metabolism, Merck & Co., Inc, 126 East Lincoln Avenue, Rahway, NJ 07065

            Synthesis of [2,2-methyl-d6]-2-(pyridinyloxy)-2,2-dimethylacetic acid from methyl acrylate (1) is described.  The key step is a Diels-Alder reaction of methyl acrylate with anthracene to protect the double bond followed by reaction with methyl-d6 Grignard reagent to introduce the deuterium labels as shown in 2.   This approach involved a retro Diels-Alder reaction to regenerate the double bond, which is then converted to an aldehyde through ozonolysis.  A one-pot procedure was developed to convert the aldehyde to the ethyl ester 3, which was then coupled with 2-chloropyridine.  Simple hydrolysis under base condition gave the title compound 4.  

 

Poster Session
7:00 PM-9:00 PM, Sunday, August 19, 2007 BCEC -- Exhibit Hall - B2, Poster

Division of Medicinal Chemistry

The 234th ACS National Meeting, Boston, MA, August 19-23, 2007